Bapten Taken Off Market

The equine tendon medication Bapten has been discontinued by its manufacturer, PR Pharmaceuticals, because of a lack of demand. The expense and length of treatment involved with Bapten therapy kept it from becoming popular, according to Keri Nightingale, the company’s marketing manager for Bapten.

“It requires a bit of commitment on the horse owner’s part,” she said. “There

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners